Market cap: $210 billion Industry: Pharmaceutical
Buy back your shares
The Swiss drug manufacturer is halfway through a $5 billion share buyback programme it announced in January.
Shares rose soon after and analysts hailed the debt-financed buyback...
Read latest Finance Asia - Corporate Treasure the Review 2016-17 online.